FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Aurobindo Pharma Recalls One Lot of Gabapentin

[ Price : $8.95]

Aurobindo Pharma recalls one lot of generic gabapentin capsules (Pfizers Neurontin), USP 300 mg 100-count bottles due to the possi...

CDER Begins Posting Demographic Subgroup Data

[ Price : $8.95]

CDER begins posting demographic subgroup data for certain approved drugs.

New FDA Warning on Power Morcellators for Hysterectomies

[ Price : $8.95]

FDA issues an updated warning against using laparoscopic power morcellators to remove the uterus (hysterectomy) or fibroids (myome...

Rep. Bilirakis Introduces Orphan Drug Exclusivity Extension Bill

[ Price : $8.95]

U.S. Rep. Gus Bilirakis (R-FL) introduces H.R. 5750, the Orphan Product Extensions Now Accelerating Cures & Treatment Act, which w...

FDA Guidance on Design Considerations for Home-use Devices

[ Price : $8.95]

FDA posts a new guidance on Design Considerations for Devices Intended for Home Use that is intended to assist manufacturers in de...

Comments Sought on Clinical Trial Subgroup Posting

[ Price : $8.95]

Federal Register Notice: FDA requests comments on a new posting on the agencys Web site: Subgroup Data for FDA Approved Products, ...

FDA Denies Allergan Petition on Restasis Bioequivalence

[ Price : $8.95]

FDA denies an Allergan petition asking FDA to not accept or approve any ANDAs for its Restasis (cyclosporine ophthalmic emulsion) ...

FDA Orphan Designation for Duchenne Therapy

[ Price : $8.95]

FDA grants Catabasis Pharmaceuticals an orphan drug designation for CAT-1004 for treating Duchenne muscular dystrophy.

Guidance on Registration of Drug Compounding Facilities

[ Price : $8.95]

Federal Register Notice: FDA releases a final guidance: Registration of Human Drug Compounding Outsourcing Facilities Under Sectio...

Panel to Discuss Astellas NDAs for Aspergillosis/Mucormycosis

[ Price : $8.95]

Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 1/22/15 to discuss Astellas Pharma NDAs for treati...